You have 9 free searches left this month | for more free features.

imatinib

Showing 1 - 25 of 124

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

Not yet recruiting
  • Inherited Bone Marrow Failure Syndrome
  • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
  • imatinib
  • TruSight Oncology
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 20, 2023

Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
  • (no location specified)
Jun 7, 2022

GIST Trial in Xi'an (Imatinib)

Recruiting
  • GIST
  • Imatinib
  • Xi'an, Shaanxi, China
    Xijing Hospital of Air Force Military Medical University
Jun 8, 2023

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

Recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Apr 24, 2023

Gastrointestinal Stromal Tumors Trial in Lexington (Imatinib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Imatinib
  • Lexington, Kentucky
    Markey Cancer Center
Aug 5, 2022

Sarcoma Trial in Helsinki (Imatinib)

Recruiting
  • Sarcoma
  • Imatinib
  • Helsinki, Finland
    Helsinki University Central Hospital
Sep 26, 2022

Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Frankfurt (Imatinib, Ponatinib, Blinatumomab)

Recruiting
  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
  • Imatinib
  • +3 more
  • Frankfurt, Germany
    Department of Medicine, Hematology and Oncology, Goethe Universi
Sep 24, 2023

Advanced, Refractory Cancer Trial in Seoul (Imatinib)

Active, not recruiting
  • Advanced, Refractory Cancer
  • Imatinib
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Tuberculosis Trial in Atlanta (Imatinib, Isoniazid, Rifabutin)

Recruiting
  • Tuberculosis
  • Imatinib
  • +2 more
  • Atlanta, Georgia
    Emory University DAIDS TB Non-Network CRS
Jan 20, 2022

CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

Not yet recruiting
  • CML, Chronic Phase
  • Harbin, Heilongjiang, China
    Institute of Hematology and Oncology, Harbin The First Hospital
May 5, 2022

ALK+ Anaplastic Large Cell Lymphoma Trial in Wien (Brentuximab vedotin, Imatinib)

Terminated
  • ALK+ Anaplastic Large Cell Lymphoma
  • Brentuximab vedotin
  • Imatinib
  • Wien, Austria
    Universitätsklinik f. Innere Medizin I, AKH Wien, Klinische Abte
Feb 15, 2022

Ph+ ALL Trial in China (Olverembatinib, Imatinib)

Recruiting
  • Ph+ ALL
  • Chongqing, Chongqing, China
  • +8 more
Sep 22, 2023

Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • Detroit, Michigan
  • +1 more
May 3, 2022

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Beijing, China
    Peking University People's Hospital(北京大学人民医院)
Jan 3, 2022

Acute Leukemia Trial in Tianjin (Flumatinib, Imatinib)

Recruiting
  • Acute Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2021

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Covid19, Coronavirus Disease 2019, SARS-CoV-2 Acute Respiratory Disease Trial in Helsinki (Imatinib, Infliximab)

Recruiting
  • Covid19
  • +2 more
  • Helsinki, Finland
    University of Helsinki
Apr 27, 2022

Progression-free Survival, Gastrointestinal Stromal Tumor, Neoadjuvant Trial in Hangzhou (Imatinib)

Recruiting
  • Progression-free Survival
  • +2 more
  • Imatinib
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 9, 2021

Gastrointestinal Stromal Tumors Trial in Seoul (imatinib)

Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • imatinib
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jun 22, 2021

Rare Malignant Tumor Trial (Imatinib)

Not yet recruiting
  • Rare Malignant Neoplasm
  • Imatinib
  • (no location specified)
Nov 1, 2023

Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

Completed
  • Chronic Myeloid Leukaemia
  • Imatinib
  • Rionero in Vulture, Potenza, Italy
  • +32 more
Oct 24, 2022

Landscape and Real-life Treatment Outcomes in Hungary: Analysis

Completed
  • Chronic Myeloid Leukaemia
  • Budapest, Hungary
    Pfizer
Dec 15, 2022